$33m revenue US based Medical Device Manufacture: Respiratory, CPAP & Sterilization

Reason for Selling

Owners health issues

Legal Constraints

none

Key Financials

year sales ebitda net income nfp
2020 USD33.00 USD6.00 USD0.00 USD0.00

Additional Information

**Main Products**
Respiratory (O2), CPAP & Sterilization equipment

Bradley Smith ATP, CMAA

Managing Director/ Partner
Vertess